VICTORY CAPITAL MANAGEMENT INC
Position in DNLI — Denali Therapeutics Inc.
CIK 1040188
San Antonio, TX
Position in DNLI
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$442,306
+$131,382 QoQ
Shares Held
17,197
+6.2% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#155
of 290 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026VICTORY CAPITAL MANAGEMENT INC holds $2,531,634,647 across 158 Biotechnology names. DNLI ranks #89 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,173,152 | $1,079,469,792 | |
| 2 | RPRX |
Royalty Pharma plc
|
3,682,932 | $206,501,997 | |
| 3 | INCY |
Incyte Corp
|
1,480,342 | $167,811,569 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
686,719 | $165,478,677 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
253,764 | $80,212,262 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
126,343 | $78,779,914 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
172,842 | $52,030,627 | |
| 8 | BNTX |
BioNTech SE
|
539,787 | $50,227,180 |
All Filings in DNLI
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $442,306 | 17,197 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $310,924 | 16,194 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $248,706 | 15,064 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $218,729 | 15,064 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $638,167 | 45,616 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $565,919 | 41,627 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $784,793 | 38,508 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $1,162,287 | 39,900 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $351,388 | 15,133 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $302,526 | 14,743 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $329,368 | 15,348 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $249,231 | 12,081 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $337,919 | 11,451 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $269,982 | 11,718 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $368,649 | 13,256 | Shares | Sole | 2023-04-25 | |
| 2022-09-30 | $356,771 | 11,625 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $320,286 | 10,883 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $350,106 | 10,883 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $538,812 | 12,081 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $1,095,168 | 21,708 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $3,303,971 | 42,121 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $2,190,070 | 38,355 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $1,555,171 | 18,567 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $446,728 | 12,468 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $317,701 | 13,139 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $238,538 | 13,623 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||